Tilelizumab
Hepatocellular Carcinoma
Explore 499 assets in Hepatocellular Carcinoma →First Affiliated Hospital of Zhejiang UniversityUNKNOWNPhase 2
—
Rating in progress
Tilelizumab in Hepatocellular Carcinoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active